What is the address of BOGAERT MEDICAL Médecine Générale?

The registered office of BOGAERT MEDICAL Médecine Générale is located at Rue des Magnolias(CG) 4, 5022 Namur.

Is BOGAERT MEDICAL Médecine Générale still active?

Yes. According to the CBE (3 October 2026) BOGAERT MEDICAL Médecine Générale is active, legal situation “Normale toestand”, started on 22 March 2012.

Is BOGAERT MEDICAL Médecine Générale registered on Peppol?

No, BOGAERT MEDICAL Médecine Générale is currently not registered on the Peppol network.

What is the enterprise number of BOGAERT MEDICAL Médecine Générale?

The enterprise number of BOGAERT MEDICAL Médecine Générale is BE0844633141.

When was BOGAERT MEDICAL Médecine Générale founded?

BOGAERT MEDICAL Médecine Générale was founded on 22 March 2012.

Who are the directors of BOGAERT MEDICAL Médecine Générale?

According to the 2024 annual accounts, the directors of BOGAERT MEDICAL Médecine Générale are: Stéphanie Bogaert.

Is BOGAERT MEDICAL Médecine Générale a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 March 2012; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did BOGAERT MEDICAL Médecine Générale make in 2024?

BOGAERT MEDICAL Médecine Générale posted a profit after taxes of € 46,539 in financial year 2024.

What is the revenue of BOGAERT MEDICAL Médecine Générale?

As a small company, BOGAERT MEDICAL Médecine Générale is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 87,087.

BOGAERT MEDICAL Médecine Générale (Private Limited)

Dossier BOGAERT MEDICAL Médecine Générale, printed on 3 October 2026 from databakkes.be/en/0844633141/bogaert-medical-medecine-generale. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2024

BOGAERT MEDICAL Médecine Générale from Namur, company number BE0844633141, closed financial year 2024 with a result of € 46,539 after tax. For that financial year BOGAERT MEDICAL Médecine Générale recorded a gross margin of € 87,087 and equity of € 177,052. Compared with financial year 2023, the result moved from € 51,741 to € 46,539. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 29, 2025.

What it is worth Growing

€ 177,052

▲ 36% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 46,539

▼ 10% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 178,681

▲ 36% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 164,652.

People and assets in 2024

Vehicles and equipment

€ 2,278

▲ 56% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt ≈ 16 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 222,222

▼ 6% vs 2023

€ 13,918 is repaid this year. At this pace the long-term loan is gone in ≈ 16 years.

Owed to suppliers

€ 13,374

▲ 34% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 8,806

▼ 18% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 80,568 Gross margin 2021: € 80,568 First fiscal year in the series	€ 71,700 Gross margin 2022: € 71,700 ▼ 11% vs 2021 (€ 80,568) Unfavourable step	€ 95,337 Gross margin 2023: € 95,337 ▲ 33% vs 2022 (€ 71,700) Favourable step	€ 87,087 Gross margin 2024: € 87,087 ▼ 9% vs 2023 (€ 95,337) Unfavourable step	▼ 9%
Profit after taxes	€ 41,812 Profit after taxes 2021: € 41,812 First fiscal year in the series	€ 34,852 Profit after taxes 2022: € 34,852 ▼ 17% vs 2021 (€ 41,812) Unfavourable step	€ 51,741 Profit after taxes 2023: € 51,741 ▲ 48% vs 2022 (€ 34,852) Favourable step	€ 46,539 Profit after taxes 2024: € 46,539 ▼ 10% vs 2023 (€ 51,741) Unfavourable step	▼ 10%
Equity	€ 43,920 Equity 2021: € 43,920 First fiscal year in the series	€ 78,772 Equity 2022: € 78,772 ▲ 79% vs 2021 (€ 43,920) Favourable step	€ 130,512 Equity 2023: € 130,512 ▲ 66% vs 2022 (€ 78,772) Favourable step	€ 177,052 Equity 2024: € 177,052 ▲ 36% vs 2023 (€ 130,512) Favourable step	▲ 36%
Total debts	€ 344,043 Total debts 2021: € 344,043 First fiscal year in the series	€ 256,095 Total debts 2022: € 256,095 ▼ 26% vs 2021 (€ 344,043) Favourable step	€ 260,916 Total debts 2023: € 260,916 ▲ 2% vs 2022 (€ 256,095) Unfavourable step	€ 256,072 Total debts 2024: € 256,072 ▼ 2% vs 2023 (€ 260,916) Favourable step	▼ 2%
Cash	€ 102,899 Cash 2021: € 102,899 First fiscal year in the series	€ 46,845 Cash 2022: € 46,845 ▼ 54% vs 2021 (€ 102,899) Unfavourable step	€ 130,928 Cash 2023: € 130,928 ▲ 179% vs 2022 (€ 46,845) Favourable step	€ 178,681 Cash 2024: € 178,681 ▲ 36% vs 2023 (€ 130,928) Favourable step	▲ 36%
Land & buildings	€ 254,487 Land & buildings 2021: € 254,487 First fiscal year in the series	€ 242,920 Land & buildings 2022: € 242,920 ▼ 5% vs 2021 (€ 254,487) Unchanged	€ 231,352 Land & buildings 2023: € 231,352 ▼ 5% vs 2022 (€ 242,920) Unchanged	€ 219,784 Land & buildings 2024: € 219,784 ▼ 5% vs 2023 (€ 231,352) Unchanged	▼ 5%
Retained profit	€ 31,520 Retained profit 2021: € 31,520 First fiscal year in the series	€ 66,372 Retained profit 2022: € 66,372 ▲ 111% vs 2021 (€ 31,520) Favourable step	€ 118,112 Retained profit 2023: € 118,112 ▲ 78% vs 2022 (€ 66,372) Favourable step	€ 164,652 Retained profit 2024: € 164,652 ▲ 39% vs 2023 (€ 118,112) Favourable step	▲ 39%
Dividend	€ 70,142 Dividend 2021: € 70,142 First fiscal year in the series	€ 0 Dividend 2022: € 0 ▼ 100% vs 2021 (€ 70,142) Unchanged	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 263,247 Bank debt 2021: € 263,247 First fiscal year in the series	€ 249,692 Bank debt 2022: € 249,692 ▼ 5% vs 2021 (€ 263,247) Favourable step	€ 236,018 Bank debt 2023: € 236,018 ▼ 5% vs 2022 (€ 249,692) Favourable step	€ 222,222 Bank debt 2024: € 222,222 ▼ 6% vs 2023 (€ 236,018) Favourable step	▼ 6%
Balance sheet total	€ 387,963 Balance sheet total 2021: € 387,963 First fiscal year in the series	€ 334,867 Balance sheet total 2022: € 334,867 ▼ 14% vs 2021 (€ 387,963) Unchanged	€ 391,428 Balance sheet total 2023: € 391,428 ▲ 17% vs 2022 (€ 334,867) Unchanged	€ 433,123 Balance sheet total 2024: € 433,123 ▲ 11% vs 2023 (€ 391,428) Unchanged	▲ 11%

Key figures of BOGAERT MEDICAL Médecine Générale, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to BOGAERT MEDICAL Médecine Générale?

What happened at BOGAERT MEDICAL Médecine Générale in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 29, 2025 New annual accounts for financial year 2024: profit of € 46,539 (▼ 10% vs 2023). filed late Source: NBB ↗
Mar 22, 2012 New establishment in Namur. KBO
Mar 22, 2012 Start of the company according to the CBE. KBO
2011 Stéphanie Bogaert became a director. NBB

In short

From € 41,812 profit in 2021 to € 46,539 profit in 2024.

Paid € 66,538 in corporate taxes since 2021.

Best year ever: 2023, with € 51,741 profit.

Paid out € 70,142 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at BOGAERT MEDICAL Médecine Générale? We notify you, reason included.

Follow BOGAERT MEDICAL Médecine Générale

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Stéphanie Bogaert

BOGAERT MEDICAL Médecine Générale

Behind BOGAERT MEDICAL Médecine Générale is Stéphanie Bogaert.

See the full network in the app

Directors

According to the 2024 annual accounts

Stéphanie Bogaert

Administrator-manager

since 2011

Establishments

Establishment units

Physical locations of this company

Registered office

Rue des Magnolias(CG) 4

5022 Namur

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0844.633.141
VAT number: BE 0844.633.141
Registered office: Rue des Magnolias(CG) 4, 5022 Namur
Names & denominations: BOGAERT MEDICAL Médecine Générale
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 22 March 2012
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗